A note on this column: This article is general medical information, not a description of a service offered at this practice. Dr. Ishiguro's surgical practice is focused on hip and knee conditions — he does not treat De Quervain's tenosynovitis or other hand and wrist tendon disorders. This column is written to help readers understand a common condition and know when and how to seek the right specialist, typically a hand surgeon or a physiotherapist with hand and wrist expertise.

What De Quervain's tenosynovitis actually is

De Quervain's tenosynovitis (also called De Quervain's disease or De Quervain's syndrome) is inflammation and thickening of the sheath surrounding two tendons that run along the thumb side of the wrist: the abductor pollicis longus (APL) and extensor pollicis brevis (EPB). These tendons share a narrow tunnel called the first dorsal compartment, which passes over the bony bump at the end of the radius (the radial styloid) on their way to the thumb. When the sheath around them becomes irritated and swells, the tunnel becomes relatively too small for the tendons gliding through it — producing pain, tenderness, and sometimes a noticeable thickening or "bump" right at the base of the thumb.

The condition is named after Fritz de Quervain, the Swiss surgeon who first described it in 1895. It is considered a form of overuse or repetitive-strain tendinopathy, most often triggered by repeated thumb extension and abduction combined with wrist movement — the exact motion involved in wringing out a cloth, lifting an infant under the arms, or scrolling and typing on a phone for long stretches.

Who gets it, and why

De Quervain's tenosynovitis is markedly more common in women, who are affected roughly six times more often than men, and it is strongly associated with two life stages: the peri-menopausal years (roughly ages 40–60) and pregnancy or the postpartum period, when it is sometimes informally called "mommy thumb" or "baby wrist." The repeated wrist-and-thumb motion involved in lifting and holding an infant, combined with fluid retention and hormonal changes affecting connective tissue during pregnancy and lactation, is thought to explain much of this pattern.

Recognised risk factors

What the evidence shows: A 2024 cohort study of postpartum women found that pregnancy lasting more than 40 weeks (odds ratio 5.81), first childbirth (odds ratio 2.23), and a body mass index above 25 (odds ratio 2.08) were each independently associated with higher odds of developing De Quervain's tenosynovitis after delivery (Daglan et al., Hand, 2024). A separate nationwide, population-based study in South Korea covering roughly 1.6 million pregnancies found the cumulative incidence of pregnancy-related disease was about 2.1% between 2013 and 2017, with older maternal age, multiple gestation, cesarean delivery, hypertensive disorders of pregnancy, and rheumatoid arthritis also identified as risk factors (Bae et al., Clinics in Orthopedic Surgery, 2023).

How the diagnosis is made

De Quervain's tenosynovitis is primarily a clinical diagnosis, made through history and a focused physical examination rather than imaging. The classic finding is tenderness directly over the radial styloid, sometimes with visible swelling or a firm, thickened cord in that area. The best-known clinical test is the Finkelstein test, in which the examiner gently grasps the patient's thumb and deviates the wrist toward the little-finger side; sharp pain over the first dorsal compartment supports the diagnosis. A related test, the Eichhoff test — in which the patient tucks the thumb into a fist before the wrist is deviated — is often used interchangeably in casual practice but is known to produce more false positives than the original Finkelstein manoeuvre, since it can also aggravate the nearby thumb joint.

Because several other conditions can mimic De Quervain's, a careful exam also checks for these alternatives: intersection syndrome, which causes pain and crepitus a few centimetres further up the forearm, where the first and second tendon compartments cross; basal joint (CMC) arthritis of the thumb, assessed with a grind test and more common in older patients; and, less commonly, carpal tunnel syndrome or scaphoid pathology, which can produce overlapping wrist symptoms. Imaging is not usually required to make the diagnosis, but ultrasound or MRI may be used when the clinical picture is unclear, when planning an image-guided injection, or when a coexisting problem is suspected.

What the evidence says about treatment

Treatment for De Quervain's tenosynovitis is almost always conservative first, with surgery reserved for the minority of cases that don't respond. A typical first step is activity modification and a thumb spica splint that immobilises the wrist and thumb, sometimes combined with anti-inflammatory medication. For most patients whose symptoms don't fully settle with rest and splinting alone, a corticosteroid injection into the first dorsal compartment is the next step, and it has one of the strongest evidence bases of any treatment for this condition.

What the evidence shows: A randomised, placebo-controlled trial in general practice found that patients receiving a corticosteroid injection had a 78% short-term treatment response rate at one week, compared with 25% in the placebo group (Peters-Veluthamaningal et al., BMC Musculoskeletal Disorders, 2009). A separate systematic review of observational studies found that around 83% of wrists treated with corticosteroid injection alone were cured, compared with only about 14% treated with splinting alone — though injection and splinting are often used together in practice rather than as strict alternatives.

A comprehensive 2024 network meta-analysis pooling multiple randomised trials helps clarify how the various non-surgical options compare with one another, rather than only against placebo.

What the evidence shows: A 2024 network meta-analysis of randomised controlled trials for De Quervain's tenosynovitis found that corticosteroid injection combined with a period of casting or splinting ranked among the most effective non-surgical strategies overall, while extracorporeal shockwave therapy performed best for short-term pain relief specifically. The analysis also cautioned that some other isolated injectable treatments did not show a clear benefit over placebo, underscoring that not all non-surgical options carry equal evidence (Chong et al., Journal of Hand Surgery, 2024). Clinical experience also suggests that a second corticosteroid injection, when the first provides only partial relief, meaningfully increases the overall proportion of patients who avoid further intervention.

ApproachTypical roleWhat to expect
Splinting + activity changeFirst-line for mild, early symptomsReduces mechanical irritation; often combined with an injection for faster relief
Corticosteroid injectionStandard step for most persistent casesWell-supported response rates; a second injection is sometimes offered if relief is partial
Extracorporeal shockwave therapySecondary or adjunct optionShown to outperform placebo for short-term pain in trial data
Surgical releaseReserved for cases unresponsive to conservative careHigh reported satisfaction and low complication rates in published series

When surgery becomes the right conversation

For the minority of patients whose symptoms persist despite splinting and one or more corticosteroid injections given a fair trial, surgical release of the first dorsal compartment is a well-established option. The procedure involves incising the constricting sheath to give the APL and EPB tendons more room to glide, and it is usually done as a day surgery under local or regional anaesthesia.

What the evidence shows: Published surgical series consistently report favourable outcomes: one series of 43 wrists followed for an average of three years reported a 91% cure rate with 88% of patients fully satisfied, while functional outcome scores (QuickDASH) have been shown to improve substantially after release, alongside meaningful reductions in pain scores. Complication rates are generally low, with the most frequently reported issues being scar tenderness and, less often, temporary irritation of the sensory nerve branch that runs near the compartment — a structure surgeons take particular care to identify and protect during the procedure.

When to see a specialist

Thumb-side wrist pain that doesn't improve within a few weeks of rest and activity modification, or that interferes with daily tasks like lifting a child or gripping objects, is worth a proper clinical evaluation rather than self-diagnosis — particularly because basal joint arthritis and intersection syndrome can feel similar but are managed somewhat differently. This is especially relevant for anyone who is pregnant or in the first year postpartum, given how strongly this period is linked to the condition, and for anyone with a known inflammatory arthritis, who may need broader evaluation alongside local treatment.

References (PubMed / Journal)

Chong HH, Pradhan A, Dhingra M, Liong W, Hau MYT, Shah R. Advancements in de Quervain Tenosynovitis Management: A Comprehensive Network Meta-Analysis. J Hand Surg Am. 2024;49(6):557–569. DOI: 10.1016/j.jhsa.2024.03.003

Daglan E, Morgan S, Yechezkel M, Frenkel Rutenberg T, Shemesh S, Iordache SD, Kadar A. Risk Factors Associated With de Quervain Tenosynovitis in Postpartum Women. Hand (N Y). 2024. DOI: 10.1177/15589447221150524

Bae KJ, Baek GH, Lee Y, Lee J, Jo YG. Incidence and Risk Factors for Pregnancy-Related de Quervain's Tenosynovitis in South Korea: A Population-Based Epidemiologic Study. Clin Orthop Surg. 2023;15(1):141–148. DOI: 10.4055/cios22099

Peters-Veluthamaningal C, Winters JC, Groenier KH, Meyboom-de Jong B. Randomised controlled trial of local corticosteroid injections for de Quervain's tenosynovitis in general practice. BMC Musculoskelet Disord. 2009;10:131. DOI: 10.1186/1471-2474-10-131